SFC

Découvrez l'article du mois de mars des Archives of Cardiovascular Diseases, la revue scientifique en anglais de la SFC : 
Usefulness of perioperative transoesophageal echocardiography during paediatric cardiac surgery 
Pierrick Pyra, Khaled Hadeed, Aitor Guitarte Vidaurre, Rémi Vincent, Yves Dulac, Gérald Chausseray, David Felice Calvaruso, Philippe Acar, Clément Karsenty

Abstract


Background: Paediatric transoesophageal echocardiography probes allow perioperative evaluation during paediatric congenital heart disease surgey.

Aim: To assess the usefulness of perioperative transoesophageal echocardiography in evaluating the severity of residual lesions, based on the type of congenital heart disease repaired in paediatric patients.

Methods: A retrospective analysis was conducted on paediatric patients who underwent open-heart surgery at our tertiary centre over a four-year period. Perioperative transoesophageal echocardiography studies were performed, and residual lesions were classified as mild, moderate or severe.

Results: Overall, 323 procedures involving 310 patients with a median age of 13.8 (0.07-214.4) months and a median weight of 8.2 (2-96) kg at intervention were enrolled in the study. Twenty-one (6.5%) residual lesions led to immediate reintervention: severe right ventricular outflow tract obstruction (n=12); severe aortic regurgitation (n=3); superior vena cava stenosis (n=2); moderate residual ventricular septal defect (n=2); severe mitral regurgitation (n=1); and severe mitral stenosis (n=1). Three (0.9%) neonates had ventilation difficulties caused by the transoesophageal echocardiography probe having to be removed, but experienced no sequelae.

Conclusion: Perioperative transoesophageal echocardiography is a safe procedure, providing information on severe residual lesions, leading to the immediate revision of several paediatric congenital heart disease cases.

Nos suggestions d’actualités

Les actualités Cardio Online

Vaccins : quand, quels patients, pour quelles pathologies et selon quelles recommandations ?

Quels objectifs de LDL-cholestérol en prévention primaire ?

TAVI : de l’innovation à la révolution de la cardiologie interventionnelle grâce au Pr Alain Cribier

Fibrillation ventriculaire

Préparation physique, gestion des entraînements : les secrets de performance de Jean Galfione

03/05/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 03/05/24

02/05/2024
Actualités SFC
Communautés

Journée des Groupes & Filiales de la SFC

29/04/2024
Actualités Congrès
Congrès

JESFC 2025 : PROLONGATION DE NOTRE APPEL À COMMUNICATION !